Nevertheless, most professional diabetes organizations continue to advocate its use [37,39,46], generally recommending that self-monitoring is performed at least three times daily in individuals treated with insulin and according to treatment regimen and level of glycaemic control in non-insulin dependent diabetes [37,38]. This evidence concerns the gene INS and diabetes mellitus.